BioForce Nanosciences Holdings, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 0.501955 million compared to USD 158.41 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 9.72 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 USD | +12.41% | +12.41% | -18.91% |
1st Jan change | Capi. | |
---|---|---|
-18.91% | 47.71M | |
-.--% | 843M | |
-1.57% | 657M | |
+3.94% | 384M | |
+21.98% | 229M | |
0.00% | 141M | |
+115.22% | 65.28M |
- Stock Market
- Equities
- BFNH Stock
- News BioForce Nanosciences Holdings, Inc.
- BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021